scholarly journals Local Anesthetic Delivered with a Dual Action Ring and Injection Applicator Reduces the Acute Pain Response of Lambs during Tail Docking

Animals ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 2242
Author(s):  
Alison Small ◽  
Danila Marini ◽  
Ian Colditz
Keyword(s):  
Acute Pain ◽  
Local Anesthetic ◽  
Dual Function ◽  
Treatment Groups ◽  
Ewe Lambs ◽  
Tail Docking ◽  
Function Ring ◽  
Dual Action ◽  
Abnormal Behaviors ◽  
Control Sham

Docking the tail of lambs is a standard husbandry procedure and is achieved through several techniques including clamps, hot or cold knives and latex rings, the last of which is the most popular. All tail docking methods cause acute pain which can be reduced by application of local anesthetic, however precise anatomical injection for optimal efficacy requires considerable skill. This pen trial evaluated the ability of local anesthetic (LA) delivered with a dual function ring applicator/injector to alleviate acute tail docking pain. Thirty ewe lambs were assigned to one of three treatment groups (n = 10 per group): ring plus local anesthetic (Ring LA), ring only (Ring) and sham handled control (Sham). Lambs were videoed and their behavior categorized every five minutes for the first hour and every 10 min for the subsequent two hours after treatment. There was a significant effect (p < 0.001) of treatment on total active pain related behaviors in the first hour, with Ring lambs showing higher counts compared to Ring LA or Sham. Ring lambs also displayed a significantly higher count of combined abnormal postures (p < 0.001) than Ring LA or Sham lambs. Delivery of 1.5 mL of 2% lignocaine via the dual action device abolished abnormal behaviors and signs of pain in Ring LA lambs. However, lambs in the Ring LA group spent less time attempting to suckle compared to Ring and Sham lambs, suggesting that some residual discomfort remained.

scholarly journals 83 Evaluation of transmammary-delivered firocoxib and an ethyl chloride spray to mitigate pain associated with processing procedures in piglets

2020 ◽  
Vol 98 (Supplement_3) ◽  
pp. 4-4
Author(s):  
Abbie V Viscardi ◽  
Elizabeth Shirtcliff ◽  
Emily Eppler ◽  
Savannah Miller ◽  
Johann Coetzee
Keyword(s):  
Production Systems ◽  
Ethyl Chloride ◽  
Hair Cortisol ◽  
Post Processing ◽  
Significant Treatment ◽  
Treatment Groups ◽  
Time Points ◽  
Tail Docking ◽  
Management Procedures ◽  
On Farm

Abstract Piglets raised in commercial production systems in the U.S. undergo painful management procedures, including surgical castration, tail docking and ear notching, without analgesia or anesthesia provision for pain relief. This is a significant animal welfare concern. There is an immediate need to identify the most practical and effective analgesia or anesthesia option for use on-farm. The objective of this study was to assess the efficacy of 2.0mg/kg firocoxib, administered to the sow and delivered transmammary to her piglets, and a vapocoolant spray (ethyl chloride) to reduce processing pain. Five-day old male and female Yorkshire-cross piglets were used. 2.0mg/kg firocoxib was administered to the sow intramuscularly 7h prior to processing piglets. An ethyl chloride spray was applied to the ears, tail and scrotum of the piglets immediately before ear notching, tail docking and surgical castration, respectively. Piglets were assigned to one of four treatment groups: firocoxib and vapocoolant spray (FV; n=32), firocoxib only (F; n=32), vapocoolant spray only (V; n=32), no treatment (CON; n=32). The observation period was from 24h pre- to 48h post-processing (specific time points = baseline, 0h, 1h, 2h, 4h, 7h, 24h, 30h, 36h, 48h). Preliminary results found piglets displayed significantly more pain-related behaviors at 24h and 30h post-processing than at most other time points (p&lt; 0.05). Piglets had significantly higher cranial temperatures at 7h post-processing than all other time points (p&lt; 0.05). There was a trend in FV and F piglets having a higher cranial temperature at 36h post-processing compared to V and CON piglets (p=0.08). All piglets had significantly higher hair cortisol levels at 4 vs 20-days old (p&lt; .0001); however, there were no significant treatment effects on cranial temperature, hair cortisol or pain behavior, suggesting firocoxib and the ethyl chloride spray were unable to significantly reduce piglet pain post-processing. Further study analysis is needed to confirm these initial findings.

scholarly journals 82 Struggle behavior and vocalizations of male piglets during castration

2020 ◽  
Vol 98 (Supplement_3) ◽  
pp. 3-4
Author(s):  
Maria E Lou ◽  
Yuzhi Li ◽  
Beth Ventura
Keyword(s):  
Birth Weight ◽  
Acute Pain ◽  
High Frequency ◽  
Video Recording ◽  
Low Frequency ◽  
Peak Frequency ◽  
Analysis Software ◽  
Chi Square ◽  
Behavioral Indicators ◽  
Treatment Groups

Abstract Castration without the use of analgesia is routinely performed on male piglets. The objective of this study was to assess acute pain during castration through behavioral indicators. Piglets (n=88) were randomly allocated to one of two treatments: castration without the use of analgesia (C) and sham-castration (S). Within 24 hours after birth (birth weight = 1.78kg ±0.71), identical procedures were followed for both treatment groups, except sham piglets were not castrated. Struggle behavior (curl ups, leg kicks, and body flailing) and vocalizations were collected via continuous video recording as piglets received treatment from start (first application of scalpel) to end (application of iodine). Vocalization parameters (duration and peak frequency) were analyzed using the Raven Pro: Interactive Sound Analysis Software (Version 1.5). Peak frequency was defined as low (&lt; 1000 Hz) and high (≥ 1000 Hz). Data were analyzed using the Glimmix Procedure of SAS. For struggle behavior, treatment did not affect curl up frequency. However, castrated piglets kicked more frequently than did sham piglets (C=28.8±0.9 vs. S=21.3±0.9 kicks/min; P=0.02). Additionally, 52% of castrated piglets displayed body flailing, whereas only 4.4% of sham piglets displayed the same behavior (Chi-Square = 24.2; P &lt; 0.0001). For vocalizations, no difference was found for duration and peak frequency of low frequency calls. However, castrated piglets responded with more high frequency calls than sham piglets (C=23.6±0.3 vs. S=18.6±0.3 calls/min; P=0.04). High frequency calls tended to be of longer duration for castrated piglets (C=0.45±0.04 vs. S=0.27±0.04 sec/call; P=0.08). Results indicate that castration without the use of analgesia increased the frequency of leg kicks, body failing, and high frequency calls. This suggests that leg kicks, body flailing, and high frequency calls maybe useful behavioral indicators of acute pain in piglets.

Ewe lamb nutrition during pregnancy affects pregnancy outcome

2008 ◽  
Vol 48 (8) ◽  
pp. 1085 ◽  
Author(s):  
F. J. Mulvaney ◽  
P. R. Kenyon ◽  
S. T. Morris ◽  
D. M. West
Keyword(s):  
Treatment Group ◽  
Survival Rates ◽  
Breeding Period ◽  
Treatment Groups ◽  
Ewe Lambs ◽  
Ewe Lamb ◽  
Pregnant Ewe ◽  
High Level ◽  
The Impact ◽  
High Treatment

This experiment aimed to investigate the impact of pregnancy nutritional treatment on ewe lamb pregnancy rate and pregnancy loss and the liveweight of resulting lambs. Two hundred and forty ewe lambs mated during a 5-day breeding period were randomly allocated to one of three nutritional regimes (‘low’, ‘medium’ and ‘high’). The low (n = 80) treatment group was fed pasture to maintain liveweight during the first 100 days of pregnancy, thereafter feeding was increased to achieve a total liveweight change of 180 g/day. The medium treatment group was fed to ensure a liveweight change equivalent to 100 g/day throughout the entire pregnancy period, while the high treatment group was offered feed ab libitum. The target liveweight changes were achieved in all ewe lamb treatment groups. Fewer (P < 0.05) ewe lambs were scanned pregnant at day 50 of pregnancy and lambed in the high treatment compared with their medium counterparts. In addition, fewer (P < 0.05) low treatment ewe lambs lambed compared with the medium treatment ewe lambs. The lower numbers lambing in the low and high treatment groups were somewhat explained by greater (P < 0.05) pregnancy losses between day 50 and term. Lambs born to low treatment ewe lambs were lighter (P < 0.05) at birth (L0), L53 and L87 and had lower (P < 0.05) survival rates than those born to either medium or high treatment ewe lambs. While the present study was not designed to identify optimal ewe lamb feeding levels in pregnancy, it clearly indicates adverse effects from either a low or high level of pregnancy nutrition beginning in early pregnancy. Therefore, further studies are required to identify the optimal pastoral feeding conditions for the pregnant ewe lamb.

Use of meloxicam, buprenorphine, and Maxilene® to assess a multimodal approach for piglet pain management, part 2: tail-docking

2019 ◽  
Vol 28 (4) ◽  
pp. 499-510 ◽  
Author(s):  
AV Viscardi ◽  
PV Turner
Keyword(s):  
Treatment Group ◽  
Multimodal Approach ◽  
Painful Procedure ◽  
Similar Frequency ◽  
Male And Female ◽  
Treatment Groups ◽  
Tail Docking ◽  
Opioid Administration ◽  
Power And Energy ◽  
Frequency Power

Piglets on commercial pig farms are often tail-docked to reduce the incidence of tail-biting. While this is a painful procedure, piglets are often not provided analgesia or anaesthesia for pain relief. The objectives of this study were to assess a multimodal approach to managing tail-docking pain in piglets, using 0.4 mg kg–1 meloxicam (MEL), 0.04 mg kg–1 buprenorphine (BUP), and Maxilene® (MAX), a topical anaesthetic. The effectiveness of each drug and drug combination was evaluated using behavioural indicators, vocalisation, and facial grimace analysis. This study also assessed whether male and female piglets responded differently to pain or pain treatments. Piglets were randomly assigned to one of six possible treatments: MEL, BUP, MEL + BUP, MEL + BUP + MAX, no treatment (tail-docked control), or sham (non-tail-docked control). Vocalisations were recorded at initial handling, injection, and tail-docking. Piglets administered MEL + BUP and BUP demonstrated significantly fewer pain behaviours than piglets in the MEL and no treatment group. MEL + BUP + MAX and BUP piglets displayed significantly lower facial grimace scores than piglets in the no treatment group. There were no significant differences in emitted vocalisations between the analgesia-treated piglets and the no treatment group and both injection and tail-docking elicited piglet vocalisations of similar frequency, power, and energy. There were no significant differences in behaviour, facial grimacing or emitted vocalisations between male and female piglets. All treatment groups with buprenorphine were able to alleviate tail-docking-associated pain, suggesting that opioid administration is highly effective for managing piglet pain.

scholarly journals Salivary microRNAs are potential biomarkers for the accurate and precise identification of inflammatory response after tail docking and castration in piglets

2020 ◽  
Vol 98 (5) ◽  
Author(s):  
Cristina Lecchi ◽  
Valentina Zamarian ◽  
Chiara Gini ◽  
Chiara Avanzini ◽  
Alessia Polloni ◽  
...  
Keyword(s):  
Salivary Cortisol ◽  
Stressful Events ◽  
Receiver Operating Curve ◽  
Control Group ◽  
Treatment Groups ◽  
Tail Docking ◽  
Inflammatory Protein ◽  
Group 12 ◽  
Factor Alpha ◽  
Potential Biomarkers

Abstract The present study aimed to investigate whether acute pain associated with castration and tail docking of male piglets may modulate the expression of salivary microRNAs (miRNAs) and to explore their potential use as biomarkers. Thirty-six healthy 4-d-old piglets (Hermitage × Duroc) were randomly assigned to three groups: the first group (12 piglets) has been pretreated with anesthetic and anti-inflammatory drugs (ANA) and then castrated and tail docked; the second one (12 piglets) has been castrated and tail docked without any drugs (CONV); the third one (12 piglets) has been only handled (SHAM). Saliva was collected 10 min before (control group) and 30 to 45 min after the procedures. Salivary cortisol has been quantified. The expression concentrations of seven miRNAs, namely miR-19b, miR-27b-3p, miR-215, miR-22-3p, miR-155-5p, hsa-miR-365-5p, and hsa-miR-204, were measured and assessed as potential biomarkers of pain by quantitative Polimerase Chain Reaction using TaqMan probes. The area under the receiver operating curve (AUC) was used to evaluate the diagnostic performance of miRNAs. The concentration of salivary cortisol increased after treatment in CONV and ANA, while no significant variation was observed in the SHAM group. The comparative analysis demonstrated that the concentrations of salivary miR-19b (P = 0.001), miR-27b (P = 0.042), and miR-365 (P &lt; 0.0001) were significantly greater in CONV as compared with pretreatment. The AUC of pretreatment vs. CONV and CONV vs. ANA were excellent for miR-19b and miR-365 and fair for miR-27b. Combining two miRNAs, namely miR-19b and miR-365, in a panel increased the efficiency of distinguishing between pre- and post-treatment groups. No differences have been identified between SHAM and ANA groups. mRNA potential targets of differentially expressed-miRNA were investigated, and genes related to pain and inflammation were identified: miR-19b potentially modulates TGF-beta and focal adhesion pathways, miR-365 regulates cytokines expression (i.e., IL-1, Tumor Necross Factor-alpha, and IL-8 cytokine), and miR-27b regulates macrophage inflammatory protein pathways (i.e., MIP1-beta). In conclusion, we demonstrated that the abundance of miR-19b, miR-27b, and miR-365 increases in the saliva of piglets castrated and tail docked without the administration of pain-relieving drugs. Further studies are needed to assess their potential during routine husbandry procedures and to extend their assessment in other stressful events, such as weaning or chronic pain.

Do psychological and physiological stressors alter the acute pain response to castration and tail docking in lambs?

2011 ◽  
Vol 38 (2) ◽  
pp. 134-145 ◽  
Author(s):  
Corinna Clark ◽  
Mike Mendl ◽  
Jennifer Jamieson ◽  
Ashleigh Arnone ◽  
Avril Waterman-Pearson ◽  
...  
Keyword(s):  
Acute Pain ◽  
Pain Response ◽  
Tail Docking ◽  
Physiological Stressors

scholarly journals The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

2021 ◽  
Author(s):  
Andrea L. Cathcart ◽  
Colin Havenar-Daughton ◽  
Florian A. Lempp ◽  
Daphne Ma ◽  
Michael Schmid ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Severe Acute Respiratory Syndrome ◽  
Host Cells ◽  
Infection Model ◽  
Dual Function ◽  
Resistance Mutations ◽  
Viral Respiratory Infection ◽  
Dual Action

ABSTRACTVIR-7831 and VIR-7832 are dual action monoclonal antibodies (mAbs) targeting the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-7831 and VIR-7832 were derived from a parent antibody (S309) isolated from memory B cells of a 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) survivor. Both mAbs contain an “LS” mutation in the Fc region to prolong serum half-life and potentially enhance distribution to the respiratory mucosa. In addition, VIR-7832 encodes an Fc GAALIE mutation that has been shown previously to evoke CD8+ T-cells in the context of an in vivo viral respiratory infection. VIR-7831 and VIR-7832 potently neutralize live wild-type SARS-CoV-2 in vitro as well as pseudotyped viruses encoding spike protein from the B.1.1.7, B.1.351 and P.1 variants. In addition, they retain activity against monoclonal antibody resistance mutations that confer reduced susceptibility to currently authorized mAbs. The VIR-7831/VIR-7832 epitope does not overlap with mutational sites in the current variants of concern and continues to be highly conserved among circulating sequences consistent with the high barrier to resistance observed in vitro. Furthermore, both mAbs can recruit effector mechanisms in vitro that may contribute to clinical efficacy via elimination of infected host cells. In vitro studies with these mAbs demonstrated no enhancement of infection. In a Syrian Golden hamster proof-of concept wildtype SARS-CoV-2 infection model, animals treated with VIR-7831 had less weight loss, and significantly decreased total viral load and infectious virus levels in the lung compared to a control mAb. Taken together, these data indicate that VIR-7831 and VIR-7832 are promising new agents in the fight against COVID-19.

Sign in / Sign up

Export Citation Format

Share Document